THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Lauren Dockery

Concepts (67)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
6
2025
563
1.360
 Why?
Neoplasm Recurrence, Local
3
2022
309
1.290
 Why?
Uterine Cervical Neoplasms
2
2022
277
1.140
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
33
0.730
 Why?
Vulvar Neoplasms
1
2021
25
0.730
 Why?
Carcinoma in Situ
1
2021
44
0.720
 Why?
Endometrial Neoplasms
1
2022
184
0.700
 Why?
Disease Management
1
2021
84
0.700
 Why?
Platinum Compounds
1
2019
13
0.670
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
367
0.620
 Why?
Patient Navigation
1
2018
5
0.610
 Why?
United States Indian Health Service
1
2018
14
0.600
 Why?
Phthalazines
1
2017
22
0.570
 Why?
Piperazines
1
2017
45
0.570
 Why?
Neoplasms, Glandular and Epithelial
1
2017
67
0.560
 Why?
Antineoplastic Agents
1
2019
656
0.440
 Why?
Indians, North American
1
2018
508
0.440
 Why?
Bevacizumab
2
2022
93
0.360
 Why?
Female
9
2025
14462
0.340
 Why?
Molecular Targeted Therapy
2
2020
123
0.310
 Why?
Retrospective Studies
4
2024
2444
0.270
 Why?
Aged, 80 and over
3
2025
1927
0.260
 Why?
Aged
4
2025
5169
0.260
 Why?
CD47 Antigen
1
2025
4
0.240
 Why?
Humans
9
2025
26856
0.240
 Why?
CD40 Antigens
1
2025
14
0.240
 Why?
Neoadjuvant Therapy
1
2024
67
0.220
 Why?
Prealbumin
1
2022
4
0.210
 Why?
Endometrium
1
2022
38
0.200
 Why?
Cervix Uteri
1
2022
63
0.190
 Why?
Indoles
1
2022
98
0.190
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.190
 Why?
Vulva
1
2021
5
0.180
 Why?
Indazoles
1
2020
16
0.180
 Why?
Papillomaviridae
1
2021
85
0.180
 Why?
Piperidines
1
2020
42
0.170
 Why?
Fallopian Tube Neoplasms
1
2020
49
0.170
 Why?
Middle Aged
3
2025
6825
0.170
 Why?
Peritoneal Neoplasms
1
2020
76
0.170
 Why?
Adult
3
2025
7389
0.160
 Why?
Papillomavirus Infections
1
2021
137
0.160
 Why?
Disease-Free Survival
1
2019
225
0.160
 Why?
Clinical Trials, Phase II as Topic
1
2017
23
0.150
 Why?
Patient Compliance
1
2018
75
0.150
 Why?
Clinical Trials, Phase I as Topic
1
2017
26
0.150
 Why?
Disease Progression
1
2019
450
0.150
 Why?
Treatment Outcome
2
2020
2267
0.130
 Why?
Randomized Controlled Trials as Topic
1
2017
358
0.130
 Why?
Risk Factors
1
2021
2017
0.120
 Why?
Age Factors
1
2017
716
0.120
 Why?
Prospective Studies
1
2017
1219
0.110
 Why?
United States
1
2018
2035
0.100
 Why?
Young Adult
1
2018
2584
0.090
 Why?
Adolescent
1
2018
2960
0.090
 Why?
Immunoglobulin Fc Fragments
1
2025
4
0.060
 Why?
Recombinant Fusion Proteins
1
2025
228
0.060
 Why?
Drug Resistance, Neoplasm
1
2025
146
0.050
 Why?
Interleukin-8
1
2022
44
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
31
0.050
 Why?
Vitamin D
1
2022
44
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
108
0.050
 Why?
Predictive Value of Tests
1
2024
472
0.050
 Why?
Interleukin-6
1
2022
190
0.050
 Why?
Pilot Projects
1
2022
391
0.050
 Why?
Biomarkers
1
2022
731
0.040
 Why?
Prognosis
1
2020
758
0.040
 Why?
Postoperative Complications
1
2022
605
0.040
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (18)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES